Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody

被引:105
|
作者
Luftig, Micah A.
Mattu, Marco
Di Giovine, Paolo
Geleziunas, Romas
Hrin, Renee
Barbato, Gaetano
Bianchi, Elisabetta
Miller, Michael D.
Pessi, Antonello
Carfi, Andrea
机构
[1] Ist Ric Biol Mol P Angeletti, I-00040 Monte Porzio Catone, Italy
[2] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA
关键词
D O I
10.1038/nsmb1127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elicitation of potent and broadly neutralizing antibodies is an important goal in designing an effective human immunodeficiency virus-1 (HIV-1) vaccine. The HIV-1 gp41 inner-core trimer represents a functionally and structurally conserved target for therapeutics. Here we report the 2.0-angstrom-resolution crystal structure of the complex between the antigen-binding fragment of D5, an HIV-1 cross-neutralizing antibody, and 5-helix, a gp41 inner-core mimetic. Both binding and neutralization depend on residues in the D5 CDR H2 loop protruding into the conserved gp41 hydrophobic pocket, as well as a large pocket in D5 surrounding core gp41 residues. Kinetic analysis of D5 mutants with perturbed D5-gp41 interactions suggests that D5 persistence at the fusion intermediate is crucial for neutralization. Thus, our data validate the gp41 N-peptide trimer fusion intermediate as a target for neutralizing antibodies and provide a template for identification of more potent and broadly neutralizing molecules.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 50 条
  • [21] Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
    Reichart, T.
    Baksh, M.
    Zwick, M.
    Finn, M.
    Dawson, P.
    RETROVIROLOGY, 2012, 9
  • [22] ANALYSIS OF GP41 EPITOPES IN MODEL VIRAL MEMBRANES TO STUDY HIV-1 NEUTRALIZATION
    Reichart, Timothy M.
    Dawson, Philip E.
    BIOPOLYMERS, 2011, 96 (04) : 522 - 522
  • [23] Analysis of gp41 epitopes in model viral membranes to study HIV-1 neutralization
    T Reichart
    M Baksh
    M Zwick
    M Finn
    P Dawson
    Retrovirology, 9
  • [24] Modeling the antibody-eliciting conformation of the HIV-1 gp41 MPER
    McCully, Michelle E.
    Hannigan, Brett T.
    DeGrado, William F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [25] Capture of an early fusion-active conformation of HIV-1 gp41
    Rika A. Furuta
    Carl T. Wild
    Yongkai Weng
    Carol D. Weiss
    Nature Structural Biology, 1998, 5 : 276 - 279
  • [26] Cholesterol as a Modulator of the HIV-1 gp41 Fusion Domain's Function
    Ivankin, Andrey
    Gidalevitz, David
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 634 - 634
  • [27] Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41
    Zhou, Guangyan
    Chu, Shidong
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (10) : 1818 - 1826
  • [28] Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor
    Deng, Yiqun
    Zheng, Qi
    Ketas, Thomas J.
    Moore, John P.
    Lu, Min
    BIOCHEMISTRY, 2007, 46 (14) : 4360 - 4369
  • [29] Capture of an early fusion-active conformation of HIV-1 gp41
    Furuta, RA
    Wild, CT
    Weng, YK
    Weiss, CD
    NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) : 276 - 279
  • [30] Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket
    Bai, Yu
    Xue, Huifang
    Wang, Kun
    Cai, Lifeng
    Qiu, Jiayin
    Bi, Shuangyu
    Lai, Luhua
    Cheng, Maosheng
    Liu, Shuwen
    Liu, Keliang
    AMINO ACIDS, 2013, 44 (02) : 701 - 713